TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Cost of Revenue

Annual figures by period end, from SEC filings.

$42.63M
Year ended 2025-12-31
-13.2%
3-year compound annual growth
-3.9%
5-year compound annual growth
$65.25M2019-12-31: $47.42M2020-12-31: $51.90M2021-12-31: $64.23M2022-12-31: $65.25M2023-12-31: $63.90M2024-12-31: $63.61M2025-12-31: $42.63M$42.63M
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$42.63M-33.0%2026-04-29, From 2025-01-01
2024-12-31$63.61M-0.5%2026-04-29, From 2024-01-01
2023-12-31$63.90M-2.1%2026-04-29, From 2023-01-01
2022-12-31$65.25M+1.6%2025-04-25, From 2022-01-01
2021-12-31$64.23M+23.8%2024-04-24, From 2021-01-01
2020-12-31$51.90M+9.5%2023-08-29, From 2020-01-01
2019-12-31$47.42Mn/a2022-07-29, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$42.63M-33.0%
LENSAR, Inc. (LNSR)2025-12-31$31.31M+13.3%
CVRx, Inc. (CVRX)2025-12-31$8.31M-0.3%
AVITA Medical, Inc. (RCEL)2025-12-31$12.79M+40.7%
Apyx Medical Corp (APYX)2025-12-31$19.80M+5.6%
Carlsmed, Inc. (CARL)2025-12-31$12.47M+75.2%
Sight Sciences, Inc. (SGHT)2025-12-31$10.70M-7.6%
PRO DEX Inc (PDEX)2026-06-30$53.21M+13.0%
Shoulder Innovations, Inc. (SI)2025-12-31$11.12M+52.6%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗